BCM
Biomark Capital Management Portfolio holdings
AUM
$8.91M
This Quarter Return
+37.69%
1 Year Return
+97.06%
3 Year Return
+113.74%
5 Year Return
–
10 Year Return
–
AUM
$8.91M
AUM Growth
+$8.91M
(+38%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
ADMA Biologics
ADMA
$4.1B
| $8.9M | 99.96% |
1,433,304
| – | – |
|
|
MBVX
2
DELISTED
MABVAX THERAPEUTICS HLDGS INC
MBVX
| $4K | 0.04% |
8,903
| – | – |
|